Semaglutide
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
Novo Nordisk · Phase 3 · Completed · Enrollment 512
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide 7.2 mg | 89 participants | 51 participants | 56 participants | n/r | 4 |
| Semaglutide 2.4 mg | 29 participants | 14 participants | 21 participants | n/r | 1 |
| Placebo | 12 participants | 3 participants | 9 participants | n/r | 1 |
A count stays a count. This page does not turn a count into a percent.